Published in Dement Geriatr Cogn Disord on January 01, 2002
Delirium in the emergency department: an independent predictor of death within 6 months. Ann Emerg Med (2010) 1.51
Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study. Int J Impot Res (2013) 1.50
Review of brief cognitive tests for patients with suspected dementia. Int Psychogeriatr (2014) 1.01
The effect of cognitive impairment on the accuracy of the presenting complaint and discharge instruction comprehension in older emergency department patients. Ann Emerg Med (2011) 0.98
A growth curve model of learning acquisition among cognitively normal older adults. Exp Aging Res (2005) 0.98
Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study. Psychiatry Investig (2012) 0.98
The link between depressive symptoms, negative cognitive bias and memory complaints in older adults. Aging Ment Health (2007) 0.87
Depression, cognition, apolipoprotein e genotype: latent class approach to identifying subtype. Am J Geriatr Psychiatry (2009) 0.86
Brief cognitive assessment in a UK population sample -- distributional properties and the relationship between the MMSE and an extended mental state examination. BMC Geriatr (2005) 0.86
Internet-based screening for dementia risk. PLoS One (2013) 0.81
Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis. Sci Rep (2016) 0.78
Depressive symptoms and memory performance among older adults: results from the ACTIVE memory training intervention. J Aging Health (2012) 0.78
Long-term moderate alcohol consumption does not exacerbate age-related cognitive decline in healthy, community-dwelling older adults. Front Aging Neurosci (2015) 0.77
Methods and design of the baseline survey of the neurological disorders in Salamanca (NEDISA) cohort: a population-based study in Central-Western Spain. Neuroepidemiology (2011) 0.77
More than just a communication medium: what older adults say about television and depression. Gerontologist (2008) 0.77
PROspective MEmory Training to improve HEart failUre Self-care (PROMETHEUS): study protocol for a randomised controlled trial. Trials (2015) 0.76
Risk Factors for Possible Dementia Using the Hopkins Verbal Learning Test and the Mini-Mental State Examination in Shanghai. Diagnostics (Basel) (2015) 0.75
The cyclical lower extremity exercise for Parkinson's trial (CYCLE): methodology for a randomized controlled trial. BMC Neurol (2015) 0.75
Cluster Analysis of Physical and Cognitive Ageing Patterns in Older People from Shanghai. Diagnostics (Basel) (2016) 0.75
Relationship between sex hormones and cognitive performance in men with substance use. Drug Alcohol Depend (2012) 0.75
Brain Training with Video Games in Covert Hepatic Encephalopathy. Am J Gastroenterol (2016) 0.75
Beyond Screening: Can the Mini-Mental State Examination be Used as an Exclusion Tool in a Memory Clinic? Diagnostics (Basel) (2015) 0.75
Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med (2010) 7.39
Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med (2002) 5.80
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J (2005) 2.74
Change in physical performance over time in older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2002) 2.13
Walking speed predicts health status and hospital costs for frail elderly male veterans. J Rehabil Res Dev (2005) 1.48
Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry (2004) 1.39
Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav (2011) 1.33
Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J (2003) 1.26
Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol (2002) 1.17
Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology (2004) 1.16
Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol (2005) 1.12
Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med (2004) 1.10
Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination. Arch Clin Neuropsychol (2004) 1.01
Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa. J Neurovirol (2010) 0.97
The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail (2004) 0.96
Geographic variation in health care utilization and outcomes in veterans with acute myocardial infarction. J Gen Intern Med (2002) 0.95
Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neurosci Lett (2002) 0.93
Relationship between apolipoprotein E4 genotype and white matter integrity in HIV-positive young adults in South Africa. Eur Arch Psychiatry Clin Neurosci (2012) 0.93
Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology (2004) 0.92
Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension. J Clin Hypertens (Greenwich) (2006) 0.91
White-Matter damage in Clade C HIV-positive subjects: a diffusion tensor imaging study. J Neuropsychiatry Clin Neurosci (2011) 0.90
Blood pressure lowering and life expectancy based on a Markov model of cardiovascular events. Hypertension (2003) 0.87
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiol Aging (2013) 0.87
Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. J Clin Hypertens (Greenwich) (2007) 0.86
Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol (2003) 0.86
Association between subcortical vascular disease on CT and neuropathological findings. Int J Geriatr Psychiatry (2004) 0.85
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial. J Clin Endocrinol Metab (2015) 0.85
Regional variation in health care utilization and outcomes in ischemic stroke. J Stroke Cerebrovasc Dis (2007) 0.85
The clinically meaningful change in physical performance scores in an elderly cohort. Aging Clin Exp Res (2007) 0.85
Modelling costs of dementia in Australia: evidence, gaps, and needs. Aust Health Rev (2008) 0.83
The efficacy and safety of initial use of irbesartan/hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular risk. J Clin Hypertens (Greenwich) (2007) 0.82
The relationship between systolic blood pressure and cardiovascular risk--results of the Brisighella Heart Study. J Clin Hypertens (Greenwich) (2003) 0.82
Physician practice patterns in the treatment of isolated systolic hypertension in a primary care setting. J Clin Hypertens (Greenwich) (2002) 0.82
Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulation. Clinicoecon Outcomes Res (2011) 0.82
Hippocampal sulcal cavities: prevalence, risk factors and relationship to memory impairment. Brain Res (2010) 0.81
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria. Kidney Int Suppl (2005) 0.81
Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension. Clin Exp Hypertens (2009) 0.80
An action research protocol to strengthen system-wide inter-professional learning and practice [LP0775514]. BMC Health Serv Res (2007) 0.80
Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease. Int Psychogeriatr (2011) 0.79
NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant. BMC Med Genet (2004) 0.78
Evaluation of continuous summary physical performance scores (CSPPS) in an elderly cohort. Aging Clin Exp Res (2005) 0.77
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension. Curr Med Res Opin (2006) 0.77
Incidence of serious upper and lower gastrointestinal events in older adults with and without Alzheimer's disease. J Am Geriatr Soc (2011) 0.76
Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease. J Neuroinflammation (2006) 0.75
Broader strategies for hip fracture prevention. Am J Med (2004) 0.75
Technology, regulations, and value in health. Value Health (2004) 0.75
A clinical monitoring and management system for residential aged care facilities. Conf Proc IEEE Eng Med Biol Soc (2006) 0.75
Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment. J Am Coll Cardiol (2016) 0.75